Gene Name |
microtubule-associated protein 1 light chain 3 alpha |
TBC1 domain family, member 16 |
Image |
|
No pdb structure |
Gene Ontology Annotations |
Cellular Component |
|
|
Molecular Function |
|
|
Biological Process |
|
|
Pathways |
|
|
Drugs |
|
|
Diseases |
|
|
GWAS |
|
|
Protein-Protein Interactions |
40 interactors:
AKAP13
APP
ATG101
ATG13
ATG3
ATG4B
ATG7
BNIP3L
DVL2
EPHA7
FAM134C
FUNDC1
KIF15
KXD1
MAP1A
MAP1S
NBR1
OPTN
PIAS4
PRPF40A
RABGAP1
RABGAP1L
RDH12
RTKN
SQSTM1
SRPK1
TBC1D1
TBC1D10A
TBC1D10B
TBC1D16
TBC1D17
TBC1D2
TBC1D25
TBC1D2B
TBC1D5
TBC1D7
TBC1D9
TBC1D9B
TNIP1
TUBA4A
|
15 interactors:
GABARAPL1
KRT40
KRTAP10-5
KRTAP10-8
KRTAP10-9
KRTAP3-2
KRTAP4-12
KRTAP5-9
MAP1LC3A
NOTCH2NL
PSMA3
RGS17
RGS20
TNS2
TRAF1
|
Entrez ID |
84557 |
125058 |
HPRD ID |
03144 |
10261 |
Ensembl ID |
ENSG00000101460
|
ENSG00000167291
|
Uniprot IDs |
Q9H492
|
B9A6L7
I3L1E0
I3L4U2
Q8N3Z4
Q8TBP0
Q96DH7
|
PDB IDs |
3ECI
|
|
Enriched GO Terms of Interacting Partners? |
|
|
Tagcloud ? |
acquiring
adenocarcinoma
autophagy
became
came
constitutive
date
demethylation
egfr
erlotinib
escaping
exposing
gefitinib
ie
immunoreactivity
necessarily
neoplastic
novo
overcoming
parental
pc9
pivotal
predictor
pronounced
restores
tkis
treating
tumoural
|
|
Tagcloud (Difference) ? |
acquiring
adenocarcinoma
autophagy
became
came
constitutive
date
demethylation
egfr
erlotinib
escaping
exposing
gefitinib
ie
immunoreactivity
necessarily
neoplastic
novo
overcoming
parental
pc9
pivotal
predictor
pronounced
restores
tkis
treating
tumoural
|
|
Tagcloud (Intersection) ? |
|